Journal of Medicinal Chemistry · 1996 · 30 citations · 5 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryStructure-activity RelationshipsEnzyme InhibitionStructure-activity Relationship AnalysisTopoisomerase InhibitorsAzone AnaloguesDna Topoisomerase Ii InhibitionTopoisomerase ActivityTopoisomerase Ii FunctionTopoisomerase Ii Inhibitors
A series of novel C11-substituted derivatives of azaelliptitoxin (azatoxin) have been synthesized and tested for their inhibitory activity against human DNA topoisomerase II. Incorporation of a C11 polyamine or amine resulted in an increase in the intercalation properties of the drug and a decrease of topoisomerase II activity. The structure-activity relationship (SAR) profile of the nonintercalating C11 anilino azatoxin class follows the SAR of the (anilino)acridine family. 11-(4-Cyanoanilino)azatoxin (14) was found to be the most active analog in this series, exhibiting approximately 10-fold higher activity than azatoxin 12 and etoposide.
5
Andrew P. Thomas, C. Allott, Keith H. Gibson et al. · Journal of Medicinal Chemistry · 1992 · 91 citations · Full text
Cell death induced by topoisomerase inhibitors
Richard Bertrand, Donna Kerrigan, M Sarang et al. · Biochemical Pharmacology · 1991 · 87 citations
Pranab K. Gupta, Mahmoud Nassiri, Lisa Coleman et al. · Journal of Medicinal Chemistry · 1989 · 46 citations